Proximal Femoral Nail for Treatment of Trochanteric Femoral Fractures (Treat with Veronail)
PDF
Cite
Share
Request
Research Article
P: 165-170
December 2013

Proximal Femoral Nail for Treatment of Trochanteric Femoral Fractures (Treat with Veronail)

Namik Kemal Med J 2013;1(3):165-170
1. Namık Kemal Üniversitesi Tıp Fakültesi Ortopedi ve Travmatoloji Anabilim Dalı, Tekirdağ
2. İstanbul Bilim Üniversitesi Tıp Fakültesi Ortopedi ve Travmatoloji Anabilim Dalı, Şişli, İstanbul
No information available.
No information available
Received Date: 29.05.2013
Accepted Date: 18.12.2013
Publish Date: 06.10.2020
PDF
Cite
Share
Request

ABSTRACT

Aim:

The aim of this study is to report outcomes of 59 patients with intertrochanteric femoral fractures treated with a proximal femoral nail (Veronail)..

Materials and Methods:

We have treated 59(28 female, 31 male) patients with intertrochanteric femoral fractures by using proximal femoral nail (veronail) between years 2011 and 2012. The mean age of patients was 69.1(±13.3). The fractures were classified according to AO system. The most common fracture type was A3(n=25), followed by A1 (n=20) and A2 (n=14). The early postoperative direct radiograms and the X-rays of third month were evaluated.

Results:

In 52 of the 59 cases complete union of the fractures were achieved. One patient had a malunion that was treated with proximal femoral osteotomy. We notice in 6 of the cases proximal screw cutout on the follow up radiograms. The mean age of these patients were 77 (±7.4) years. There were two A1, two A2 and two A3 fractures according to AO system. All of these patients were revised with partial hip replacements.

Conclusion:

In our series, of the 6 patients with cutouts 2 had type A1, 2 had type A2 and 2 had type A3 fractures. The type of the fracture had no significant effect on the cutout rates. The major factor effective on the development of cutout was the osteoporosis that increases with age of the patients. Proximal femoral nail (Veronail) is a suitable device that can be used in treatment of the intertrochanteric femoral fractures safely independent of the fracture type.